Results 21 to 30 of about 10,534 (291)

The global cost of eliminating avoidable blindness

Indian Journal of Ophthalmology, 2012
Aims : To complete an initial estimate of the global cost of eliminating avoidable blindness, including the investment required to build ongoing primary and secondary health care systems, as well as to eliminate the ′backlog′ of avoidable blindness. This
Kirsten L Armstrong, Martin Jovic, Jennifer L Vo-Phuoc, Jeremy G Thorpe, Brian L Doolan   +4 more
doaj   +1 more source

Post Traumatic Total Aniridia along with Superior Subconjunctival Dislocation of Posterior Chamber Intraocular Lens: A Rare Case Report

Journal of Nobel Medical College
To report a case of post traumatic total aniridia along with superior subconjunctival dislocation of posterior chamber intraocular lens.  A 55-year-old man who underwent small incision cataract surgery with posterior chamber intraocular lens 2 years back
Birendra Roy, Sharad Gupta, Neha Kharel, Kajol Dev   +3 more
doaj   +1 more source

Beyond Nature's Blueprint: Macrocyclic Peptides Containing Unnatural Amino Acids in Therapeutic Development

Angewandte Chemie, EarlyView.
Strategic incorporation of unnatural amino acids transforms macrocyclic peptides into drug‐like molecules capable of engaging challenging targets. These building blocks enhance stability, permeability, and bioavailability, accelerating the development of next‐generation peptide therapeutics.
Krishna K. Sharma, Komal Sharma, Anku Sharma, Kamya Rao, Rahul Jain, Brett VanVeller   +5 more
wiley   +2 more sources

The Effectiveness, cost-effectiveness and acceptability of Community versus Hospital Eye Service follow-up for patients with neovascular age-related macular degeneration with quiescent disease (ECHoES): a virtual randomised balanced incomplete block trial

Health Technology Assessment, 2016
Background: Patients with neovascular age-related macular degeneration (nAMD) usually attend regular reviews, even when the disease is quiescent. Reviews are burdensome to health services, patients and carers.
Barnaby C Reeves, Lauren J Scott, Jodi Taylor, Ruth Hogg, Chris A Rogers, Sarah Wordsworth, Daisy Townsend, Alyson Muldrew, Tunde Peto, Mara Violato, Helen Dakin, Heike Cappel-Porter, Nicola Mills, Dermot O’Reilly, Simon P Harding, Usha Chakravarthy   +15 more
doaj   +1 more source

Optometrists’ scope of practice [PDF]

Clinical and Experimental Optometry, 2017
The role optometrists play in a patient's ocular and general health has increased and broadened significantly over the past decade in Australia.Landmark changes have affected the mode of practice o...
openaire   +2 more sources

Disease Course After Anti‐CD20 Discontinuation in Secondary Progressive Multiple Sclerosis—A Multicenter Long‐Term Longitudinal Study

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective To describe long‐term outcomes after anti‐CD20 discontinuation in selected patients with secondary progressive multiple sclerosis (SPMS) who remained without subsequent disease‐modifying therapy (DMT). Methods We retrospectively analyzed data from four centers in Austria and Switzerland.
Ferdinand Otto, Dariia Kliushnikova, Richard Friedrich Radlberger, Sinan Yasaroglu, Tobias Moser, Andrea Harrer, Kitty Kratzer, Wolfgang Hitzl, Christiane Gradl, Martin Schmidauer, Patrick Roth, Harald Hegen, Peter Wipfler   +12 more
wiley   +1 more source

Prevalence of Systemic Lupus Erythematosus in Australia, 2010–2022: A Population‐Based Study Using Linked National Administrative Health Data

Arthritis Care &Research, EarlyView.
Objective Systemic lupus erythematosus (SLE) is a heterogenous inflammatory condition with widely varying global prevalence estimates. The frequency of SLE in the general population of Australia has been reported to be notably lower than contemporary estimates in countries such as the United States or United Kingdom, at 19 to 39 per 100,000 as opposed ...
Lucinda Roper, Rachel Black, Joanna Tieu, Winnie Chen, Matthew Parker, Catherine Hill, Natasha Nassar, Mandana Nikpour   +7 more
wiley   +1 more source

Case Study : Rozaimi Optometrist / Nursyafina Mohd Shakeri [PDF]

, 2021
Rozaimi Optometrist is the company that I choose to investigate and gain information for accomplished the goal of case study of ENT300. This company was owned by Mohd Rozaimi bin Razali.
Mohd Shakeri, Nursyafina
core  

Making the Case for Organ‐on‐Chip Platforms in Long‐Acting Therapeutics Development

Advanced Healthcare Materials, EarlyView.
LATs release drug from a tissue‐resident depot over weeks to months, improving adherence, but their development is hampered by preclinical models that cannot reproduce the coupled tissue processes, sustained release, local microenvironment change, interstitial transport, immune and foreign‐body responses, and clearance that govern depot performance in ...
Charlie Gowans, Abdulwahhab Khedr, Panagiotis G. Georgiou, Nehir Arik, Ozlem Sen, Steve P. Rannard, Tom O. McDonald, Christos Tapeinos   +7 more
wiley   +1 more source

Ami (Heaton) Halvorson OD '07 Recognized as Optometrist of the Year

, 2022
Ami (Heaton) Halvorson OD '07 earned the Optometrist of the Year Award at the Oregon Optometric Physicians Association's annual meeting in July.Ami (Heaton) Halvorson OD '07 earned the Optometrist of the Year Award at the Oregon Optometric Physicians ...
Pacific University. Marketing and Communications
core   +1 more source